What should we do to reduce the complications of Deep brain stimulation in Parkinson's disease?
Journal Title: Neurology Letters - Year 2022, Vol 1, Issue 1
Abstract
Parkinson's Disease (PD) is one of the most common neurodegenerative disorders. Recently, Deep Brain Stimulation (DBS) was proposed as a potential therapeutic approach for PD patients. This procedure has side effects that can be divided into three categories: stimulation-related, surgery-related, and hardware-related side effects. Stimulation-related complications are also divided into motors such as paresthesia and dysarthria, while non-motor contains cognitive decline and depression. The most important complication related to surgery is intracerebral hemorrhage (ICH). Side effects related to Hardware consist mainly of erosion and infections. Choosing the appropriate patient for DBS implantation has a critical role in reducing side effects. Adaptive or closed-loop DBS stimulates the brain by adjusting the parameters in response to feedback from the body and produce electrical flow when it is. New directional leads provide the ability to shape and steer the current to avoid stimulation of unwanted regions. Using Magnetic resonance imaging (MRI) instead of Microelectrode Recording (MER) allows surgery under general anesthesia and reduces the risk of ICH. Also, Interleaving Stimulation (ILS) can be a second option for those patients whom conventional programming does not effective. Choosing the right trajectory and keeping a distance from the vascular areas during lead placement also reduces the risk of hemorrhage.Keywords: Deep brain stimulation, side effects, Adaptive DBS, Directional leads, Microelectrode recording, Parkinson's disease
Authors and Affiliations
Fardin Nabizadeh,
Keywords
Related Articles
- EP ID EP709693
- DOI 10.52547/nl.1.1.1
- Views 73
- Downloads 0
Acute relapse of Multiple Sclerosis (MS) in an adolescent patient after Tuberculin skin test (TST): a case report
Activation of MS as a result of bacterial and viral infections is proposed by various studies. However, immune responses initiated by a bacterial antigen can rarely lead to the activation or occurrence of MS. Hereby, we...
Role of Biomaterials in treatment of Alzheimer’s disease: A literature review
Currently, five medications have been approved by the FDA to treat Alzheimer's disease (AD); Donepezil, which is used at all stages of AD, galantamine, and rivastigmine for mild to moderate stages, and Memantine and a co...
Diffusion tensor imaging (DTI) and plasma p-tau 181 in Alzheimer’s disease
Alzheimer’s Disease (AD) is characterized by cognitive impairments and memory difficulties, which cause daily activities, and personal and behavioral problems. In recent years blood-based biomarkers like plasma phosphory...
Antioxidant supplements and cognition in Multiple Sclerosis: a systematic review
Background: Cognitive dysfunction is a debilitating characteristic of multiple sclerosis (MS) that affects approximately 60% of patients. To date, the only effective treatments for cognitive decline are cognitive rehabil...
Association between infection with Chlamydia pneumonia and cerebral noncardioembolic ischemic stroke
Introduction: Stroke is the third most common cause of mortality and the most common disability disorder among adults. We aimed to study the relationship between Chlamydia pneumonia infection and non-cardio Ambulatory is...